Pfizer COVID Shot: Unanimous Vote Obscures Reservations About Vaccinating All Children 5-11
Executive Summary
Many of US FDA's outside vaccine advisors wanted to wait for more data before widespread inoculations of kids 5-11, but felt some high-risk populations should get access to vaccine right away. They urged CDC to provide additional guidance on which children should be targeted.
You may also be interested in...
No Reservations: CDC Advisors Clear Pfizer COVID Vaccine For Kids With More Enthusiasm Than FDA Panel
CDC Director Walensky’s sign off on ACIP’s unanimous recommendation makes Pfizer’s COVID-19 vaccine available to all children 5 to 11 without any of the caveats some of FDA’s vaccine advisors were hoping might be added for use in this age group.
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Pfizer AdComm Asks Many Questions About COVID Vaccine For Ages 5-11, But Gets Few Answers
Often data was not available from FDA, CDC or the sponsor to answer subgroup, safety and other questions that could have influenced the outcome of the advisory committee meeting.